JSF, C., AA, G., CT, S., MJ, S., IA, M., SA, T. D., . . . JR, U. (2024). Liraglutide alleviates experimental diabetic cardiomyopathy in a PDH-dependent manner. The Journal of endocrinology, 262(2), . https://doi.org/10.1530/JOE-24-0032
Chicago Style (17th ed.) CitationJSF, Chan, et al. "Liraglutide Alleviates Experimental Diabetic Cardiomyopathy in a PDH-dependent Manner." The Journal of Endocrinology 262, no. 2 (2024). https://doi.org/10.1530/JOE-24-0032.
MLA (9th ed.) CitationJSF, Chan, et al. "Liraglutide Alleviates Experimental Diabetic Cardiomyopathy in a PDH-dependent Manner." The Journal of Endocrinology, vol. 262, no. 2, 2024, https://doi.org/10.1530/JOE-24-0032.
Warning: These citations may not always be 100% accurate.